Definition and Staging of CKM Syndrome
Carolyn S. P. Lam, MBBS, PhD, MRCP, MS, FACC, FAMS, FESC
Emerging Evidence in HF Care
Pardeep Jhund, MD, PhD
John McMurray, MD
Bridging the Gap: ns-MRAs in Cardiovascular-Kidney-Metabolic Syndrome Care
Hiddo L. Heerspink, PhD
Akshay S. Desai, MD
Csaba P. Kovesdy, MD
Finnian R. Mc Causland, MD
Orly Vardeny, MD
Muthiah Vaduganathan, MD, MPH
Nonsteroidal MRAs: The CKD/T1D Potential
MOA Deep Dive: The MRA Spectrum
Nonsteroidal MRAs: The CKD/T2D Advantage
Implementing a Multidisciplinary Approach to Heart Failure: Patient Identification and Treatment Using Novel Device Therapy
Christina Economides, MD
Brian Howard, MD
David N. Kenigsberg, MD, FACC
Myosin inhibitors: recent clinical data and applications in HCM and HF
Caroline Coats, MD
Recommendations on the management of HCM in guidelines: European vs. American views
Roberto Barriales-Villa, MD, PhD
Ahmad Masri, MD, MS
Epidemiology and clinical features of HCM
Perry Elliott, MD
Navigating therapeutic approaches in HCM: Unravelling recent evidence
Evaluation of the complex cardiac pathophysiology in HCM
Challenges of managing hyperkalemia in patients with cardiorenal disease while maintaining RAASi therapy
Gianluigi Savarese, MD
Early intervention & long-term success: Navigating hyperkalemia in cardiorenal disease
Aaron Wong, MD
James Burton, DM, FRCP
Clara Bonanad Lozano, MD, PhD
Implementing the latest evidence on novel potassium binders for achieving long-term goals
Optimizing clinical care in patients with cardiorenal disease for achieving long-term goals
Loading...
We're glad to see you're enjoying PACE-CME… but how about a more personalized experience?
Press cancel to remain on PACE-CME. Press the link below or the continue button to keep going.